Pharmacological Interventions for Osteoporosis

Evaluate the efficacy and safety of pharmacological agents used in the prevention and treatment of osteoporosis, including bisphosphonates, selective estrogen receptor modulators (SERMs), and monoclonal antibodies targeting RANKL.

    Related Conference of Pharmacological Interventions for Osteoporosis

    June 24-25, 2025

    23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    August 11-12, 2025

    5th International Conference on Endocrinology and Diabetes

    Toronto, Canada
    August 28-29, 2025

    34th International Diabetes and Healthcare Conference

    London, UK
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    September 29-30, 2025

    24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Rome, Italy
    October 27-28, 2025

    5th World Congress on Endocrine and Diabetes

    Madrid, Spain
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 03-04, 2025

    34th European Diabetes Congress

    Rome, Italy
    November 06-07, 2025

    34th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Berlin,
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 10-11, 2025

    29th International Conference on Diabetes, Endocrinology and Healthcare

    Aix-en-Provence, France
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Pharmacological Interventions for Osteoporosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in